This finding is consistent with the increased expression of Hpse in renal glomeruli (e.g., glomerular podocytes) in human diabetic nephropathy, with significant increased levels of Hpse in the urine of diabetic patients and with a selective decrease in the expression of GBM HS (55–58). This evidence concerns the gene HPSE and diabetic kidney disease.